Jalaleddini K, Bermel RA, Talente B, Weinstein D, et al. A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis. Mult Scler 2024 Feb 19:13524585241227372. doi: 10.1177/13524585241227372.
PMID: 38374525